Cargando…

Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme

OBJECTIVES: Tumour recurrence of glioblastoma multiforme (GBM) after initial treatment with surgical resection, radiotherapy and chemotherapy is an inevitable phenomenon. This retrospective cohort study compared the efficacy of interstitial high dose rate brachytherapy (HDR-BRT), re-resection and so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Archavlis, Eleftherios, Tselis, Nikolaos, Birn, Gerhard, Ulrich, Peter, Baltas, Dimos, Zamboglou, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612781/ https://www.ncbi.nlm.nih.gov/pubmed/23503605 http://dx.doi.org/10.1136/bmjopen-2012-002262

Ejemplares similares

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme
por: Chatzikonstantinou, Georgios, et al.
Publicado: (2019)

Radiobiological evaluation of the influence of dwell time modulation restriction in HIPO optimized HDR prostate brachytherapy implants
por: Mavroidis, Panayiotis, et al.
Publicado: (2010)

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
por: Behmueller, Manuel, et al.
Publicado: (2021)

High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients
por: Tselis, Nikolaos, et al.
Publicado: (2013)

A detailed dosimetric comparison between manual and inverse plans in HDR intracavitary/interstitial cervical cancer brachytherapy
por: Trnková, Petra, et al.
Publicado: (2011)

Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer
por: Chatzikonstantinou, Georgios, et al.
Publicado: (2021)

3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma
por: Ren, YuFeng, et al.
Publicado: (2014)

Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting—Ideal Versus Reality
por: Lee, Chooi Yeng, et al.
Publicado: (2016)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution
por: Yoshida, Ken, et al.
Publicado: (2023)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

HDR brachytherapy (HDR–BT) combined with stent placement in palliative treatment of esophageal cancer
por: Kanikowski, Marek, et al.
Publicado: (2009)

Spinal Intradural Intramedullary Dissemination in the Absence of Intracranial Relapse of a Previously Radically Treated Temporal Lobe Glioblastoma Multiforme
por: Serrano, Lucas, et al.
Publicado: (2017)

Radioimmunotherapy: future prospects from the perspective of brachytherapy
por: Fleischmann, Maximilian, et al.
Publicado: (2021)

The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011)

Dose correction in lung for HDR breast brachytherapy
por: Slessinger, Eric, et al.
Publicado: (2012)

Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2019)

Dosimetric analysis and comparison of IMRT and HDR brachytherapy in treatment of localized prostate cancer
por: Murali, V., et al.
Publicado: (2010)

HDR Brachytherapy in the Management of High-Risk Prostate Cancer
por: Masson, Susan, et al.
Publicado: (2012)

Dosimetric comparison of surface mould HDR brachytherapy with VMAT
por: Boman, Eeva L., et al.
Publicado: (2018)

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
por: Sim, Hao-Wen, et al.
Publicado: (2023)

Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma
por: Walter, Franziska, et al.
Publicado: (2021)

Comprehensive brachytherapy: physical and clinical aspects
por: Venselaar, Jack L M, et al.
Publicado: (2013)

Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients – Gliwice experience
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2010)

Comparison of (60)Co and (192)Ir sources in HDR brachytherapy
por: Strohmaier, Stefan, et al.
Publicado: (2011)

Ir-192 Calibration in Air with Farmer Chamber for HDR Brachytherapy
por: Chang, Liyun, et al.
Publicado: (2016)

HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator
por: Wu, Chin-Hui, et al.
Publicado: (2015)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

Comparison of two planning systems for HDR brachytherapy gynecological application
por: Elhanafy, Osman A., et al.
Publicado: (2001)

High Dose Rate (HDR) Brachytherapy for Mycosis Fungoides of the Wrist
por: Shukla, Gaurav, et al.
Publicado: (2015)

MR-guided HDR prostate brachytherapy with teleoperated steerable needles
por: de Vries, M., et al.
Publicado: (2023)

Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients
por: Sprave, Tanja, et al.
Publicado: (2022)

Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice
por: van Genugten, J. A. B., et al.
Publicado: (2009)

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems
por: Toren, Amos, et al.
Publicado: (2016)

Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide
por: Wang, Nan, et al.
Publicado: (2021)

Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy
por: Wang, Nan, et al.
Publicado: (2021)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
por: Zhao, Qian, et al.
Publicado: (2016)

High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome
por: Strouthos, Iosif, et al.
Publicado: (2021)

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9n7o70e09q4dfshl4j4n36cdgq